BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38588920)

  • 41. Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study.
    Momin AA; Shao J; Soni P; Almeida JP; Suh JH; Murphy ES; Chao ST; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
    J Neurooncol; 2021 Apr; 152(2):373-382. PubMed ID: 33590402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
    Lee A; Woods R; Mahfouz A; Kitpanit S; Cartano O; Mohamed N; Youssef I; Marqueen K; Sine K; Mah D; Neal B; Zakeri K; Kang JJ; Riaz N; Yu Y; McBride SM; Chen LD; Tsai CJ; Gelblum DY; Press RH; Michel LS; Sherman EJ; Pfister D; Dunn LA; Ho AL; Fetten J; Wong RJ; Boyle JO; Singh B; Cracchiolo JR; Ganly I; Cohen MA; Lee NY
    JAMA Netw Open; 2023 Jan; 6(1):e2250607. PubMed ID: 36689229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose escalation with proton radiation therapy for high-grade meningiomas.
    Chan AW; Bernstein KD; Adams JA; Parambi RJ; Loeffler JS
    Technol Cancer Res Treat; 2012 Dec; 11(6):607-14. PubMed ID: 22712601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma.
    Poel R; Stuessi Lobmaier A; Andratschke N; Unkelbach J; Tanadini-Lang S; Guckenberger M; Foerster R
    Br J Radiol; 2019 Aug; 92(1100):20190113. PubMed ID: 31264474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas.
    Maranzano E; Draghini L; Casale M; Arcidiacono F; Anselmo P; Trippa F; Giorgi C
    Strahlenther Onkol; 2015 Dec; 191(12):953-60. PubMed ID: 26490452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management trends for anaplastic meningioma with adjuvant radiotherapy and predictors of long-term survival.
    Alhourani A; Aljuboori Z; Yusuf M; Woo SY; Hattab EM; Andaluz N; Williams BJ
    Neurosurg Focus; 2019 Jun; 46(6):E4. PubMed ID: 31153143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
    Liu X; Shan B; Wang M; Xu J
    World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
    Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
    World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area.
    Boustani J; Ruffier A; Moya-Plana A; Tao Y; Nguyen F; Even C; Berthold C; Casiraghi O; Temam S; Blanchard P
    Strahlenther Onkol; 2021 Mar; 197(3):188-197. PubMed ID: 32514613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
    J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas.
    DiBiase SJ; Kwok Y; Yovino S; Arena C; Naqvi S; Temple R; Regine WF; Amin P; Guo C; Chin LS
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1515-9. PubMed ID: 15590183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant radiotherapy for atypical meningiomas.
    Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
    J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
    Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
    Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Re-irradiation for locally recurrent refractory breast cancer.
    Merino T; Tran WT; Czarnota GJ
    Oncotarget; 2015 Oct; 6(33):35051-62. PubMed ID: 26459388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
    Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ
    J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
    Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
    Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
    J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
    Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
    Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
    J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.